Board Growth Strategic addition of Vafa Jamali to the Board signals governance strengthening and potential for expanded strategic partnerships. Leverage board connections to access hospital systems, procurement leads, and larger medical groups.

New Product Expansion Launch of the CrossWise RF Transseptal Access System and a completed limited market release indicate active product development and field adoption. Target cardiology and electrophysiology centers that perform transseptal procedures for faster adoption and upsell of esophageal monitoring.

Esophageal Monitoring Leadership Global leadership position in high-density, rapid-response esophageal temperature monitoring presents a clear value proposition for centers performing complex ablations. Cross-sell to operators seeking precise esophageal protection during procedures and expand with broader monitoring coverage.

Moderate Revenue Potential Current revenue range and modest funding suggest growth opportunities in mid-market hospitals and regional systems. Pursue contracts with mid-tier health networks and expand into saline or non-academic centers with compatible procedure volumes.

Analytics & Partnerships Adopt and highlight utilization of cloud-ready tech stack and analytics-friendly platforms to support data-driven outcomes. Propose collaborations with systems requiring telemetry, data capture, and outcomes reporting to strengthen value proposition.